Miransertib (ARQ 092) HCl
Product Specifications
CAS Number
1313883-00-9
Synonyms
Miransertib
Target
Akt
Applications
PI3K/Akt/mTOR
Smiles
C1CC (C1) (C2=CC=C (C=C2) N3C4=C (C=CC (=N4) C5=CC=CC=C5) N=C3C6=C (N=CC=C6) N) N.Cl
Molecular Formula
C27H25ClN6
Additionnal Information
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathway inhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KRAS-456HF 20 μg- 50 μg- 100 μg
Recombinant Human KRAS Protein, His-tagged, FITC conjugated
Sign In for Pricing
View Details MBS615326-01 0.1 mg
ARFBP1 (HUWE1. HECT, UBA and WWE domain containing 1, ARF-binding protein 1, ARF-BP1, E3 ubiquitin-protein ligase HUWE1, HECT, UBA and WWE domain-containing protein 1, HectH9, HECTH9, Homologous to E6AP carboxyl terminus homologous protein 9, HSPC272, Ib7
Sign In for Pricing
View Details MBS615326-02 5x 0.1 mg
ARFBP1 (HUWE1. HECT, UBA and WWE domain containing 1, ARF-binding protein 1, ARF-BP1, E3 ubiquitin-protein ligase HUWE1, HECT, UBA and WWE domain-containing protein 1, HectH9, HECTH9, Homologous to E6AP carboxyl terminus homologous protein 9, HSPC272, Ib7
Sign In for Pricing
View Details